Diabetes: A Tale of Two Futures

diabetes, obesity, sedentary, blood glucose, sulfonylureas, insulin, metformin, glitazones, thiazolidinediones, TZDs, exenatide, dipeptidyl peptidase IV, DPP-IV, analogues, glargine, detemir, lispro, aspart, glulisine, Medicare, tale, two, futuresdiabetes, obesity, sedentary, blood glucose, sulfonylureas, insulin, metformin, glitazones, thiazolidinediones, TZDs, exenatide, dipeptidyl peptidase IV, DPP-IV, analogues, glargine, detemir, lispro, aspart, glulisine, Medicare, tale, two, futures

diabetes, obesity, sedentary, blood glucose, sulfonylureas, insulin, metformin, glitazones, thiazolidinediones, TZDs, exenatide, dipeptidyl peptidase IV, DPP-IV, analogues, glargine, detemir, lispro, aspart, glulisine, Medicare, tale, two, futuresdiabetes, obesity, sedentary, blood glucose, sulfonylureas, insulin, metformin, glitazones, thiazolidinediones, TZDs, exenatide, dipeptidyl peptidase IV, DPP-IV, analogues, glargine, detemir, lispro, aspart, glulisine, Medicare, tale, two, futures

diabetes, obesity, sedentary, blood glucose, sulfonylureas, insulin, metformin, glitazones, thiazolidinediones, TZDs, exenatide, dipeptidyl peptidase IV, DPP-IV, analogues, glargine, detemir, lispro, aspart, glulisine, Medicare, tale, two, futuresdiabetes, obesity, sedentary, blood glucose, sulfonylureas, insulin, metformin, glitazones, thiazolidinediones, TZDs, exenatide, dipeptidyl peptidase IV, DPP-IV, analogues, glargine, detemir, lispro, aspart, glulisine, Medicare, tale, two, futures